Doctors test alcohol injection to starve prostate cancer
NCT ID NCT06703437
Summary
This early-stage study is testing a new injection for men with high-risk prostate cancer. The injection uses alcohol and numbing medicine to block the nerves that feed the prostate, aiming to slow or stop the cancer's growth. Researchers will give the injection during a standard biopsy procedure to 12 participants and closely monitor safety. The goal is to find the safest dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.